Health News Releases

June 15, 11:10

BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 E

June 12, 16:50

Roquette Showcases Scalable Drug Delivery Innovations at CPHI China 2026

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, will showcase its comprehensive portfolio of innovative drug delivery solutions at CPHI & PMEC China 2026, taking pl

June 12, 15:20

Parse Biosciences Launches the Next Generation of its Immune Profiling Kits

Parse Biosciences (https://www.parsebiosciences.com/), the leading provider of scalable and accessible single cell sequencing solutions, today launched the next generation of its Evercode™ TCR (https:

June 12, 15:10

Merrithew® Expands Global Mindful Movement Leadership with Acquisition of the GYROTONIC® Organization

Merrithew®, a global leader in mindful movement education and equipment and creator of internationally recognized programs including STOTT PILATES®, ZEN·GA®, Halo® Training and Total Barre®, today ann

June 12, 11:20

Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems

Cosylab and Heron Neutron Medical Corp. announced today, 10 June 2026, the signing of a Letter of Intent to establish a strategic framework for joint market development to support the global deploymen

June 12, 10:51

Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279),

June 11, 14:45

Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments

Galderma (SIX: GALD) has released findings from a landmark global survey conducted across the United States (U.S.), Brazil, the United Kingdom (UK), and China - the largest of its kind - exploring the

June 10, 16:45

New Polymorph of Indomethacin Discovered

Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced tha

June 10, 15:00

New Study Reveals the True Environmental Impact of Periodontal Disease - And What You Can Do About It

Today P&G Oral Care announces the release of a new, first-of-its kind LCA study published in the Journal of Dentistry finds managing advanced periodontal disease can be associated with up to ~10× high

June 10, 15:00

Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Support the Company’s Advancement Toward Commercialization

Neuraptive Therapeutics today announced the appointment of Ulf Wiinberg to its Board of Directors and William “Bill” MacKenzie as Senior Vice President - Finance. Mr. Wiinberg is a seasoned biotech

June 10, 14:00

Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy

Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeuti

June 10, 12:00

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities

Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its

June 09, 17:45

Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy

Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workf

June 09, 13:30

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1

Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small caps

June 05, 11:30

New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa

A pilot study published today in Communications Medicine (https://www.nature.com/articles/s43856-026-01644-0) demonstrates the potential of a new approach to treating anorexia nervosa — a disorder for

June 03, 13:00

BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54545081&newsitemid=20260601948824&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

June 01, 15:35

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the

May 31, 12:25

Rubedo’s RLS-1496 Reduces Actinic Keratosis Pre-Cancerous Skin Lesions by 46% at Four Weeks with Minimal Irritation in Preliminary Results of Phase 1b/2a Study

Rubedo Life Sciences, Inc. (https://www.rubedolife.com/) (Rubedo), an AI-driven, clinical-stage biotech focused on selective cellular rejuvenation medicines targeting aging cells, today announced prel

May 31, 11:43

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (t

May 31, 11:40

AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine

The Access to Advanced Health Institute (AAHI), a nonprofit biotech organization dedicated to developing vaccines and technologies for global health, today congratulates Eli Lilly and Company and Cure

May 29, 12:00

BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England J

May 29, 10:00

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)

Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) (https://www.fda.gov/) has a

May 28, 14:00

Parse Biosciences and bit.bio Announce Landmark Alliance

Parse Biosciences (https://www.parsebiosciences.com/), the leading provider of scalable and accessible single cell sequencing solutions, today announced an alliance with bit.bio (https://www.bit.bio/)

May 27, 17:10

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated librar

May 27, 16:30

Mevion Medical Systems and Tam Anh General Hospital Partner to Bring Advanced Proton Therapy to Vietnam

Mevion Medical Systems has signed a definitive purchase agreement to bring the MEVION S250-FIT Proton Therapy System™ to Tam Anh General Hospital in Vietnam. This would be the first proton therapy sys

News by Region

News by Industry